Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders

Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Smiths Falls, Ontario facility (“Smiths Falls”) has received European Union Good Manufacturing Practice (“EU GMP”) certification for manufacturing and packaging activities from the Tübingen Regional Council (Regierungspräsidium Tübingen), Baden-Württemberg’s competent medicines regulatory authority in Germany.

Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany

Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum

Canopy Growth Expands European Medical Cannabis Supply into the UK

Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline

Canopy Growth Broadens Australia Medical Cannabis Portfolio with New Formats and Formulations

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the Company has mailed

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility (“Kincardine”) has received renewed European Union Good Manufacturing Practice

Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses

SMITHS FALLS, ON – July 24, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) will release its financial results for the first quarter fiscal year 2027 ended June 30, 2026 before financial markets open on August 7, 2026.